Comparison of ACE inhibitors and ARBs on incidence of major adverse cardiac events in patients with cardiovascular disease: a meta-analysis
Panpan Hao(Ningxia Medical University), Y. ZHANG(Ministry of Education of the People's Republic of China), J. WANG(Ministry of Education of the People's Republic of China), Fanggui Xu(Second Affiliated Hospital of Nanjing Medical University), Yuhao Chen(China International Science and Technology Cooperation)
Cited by 0
Related Papers
Traditional Chinese Medicine for Cardiovascular Disease
|Journal of the American College of Cardiology|2017|592
Angiotensin IV attenuates diabetic cardiomyopathy <i>via</i> suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis
|Theranostics|2021|150
Traditional Chinese medication for cardiovascular disease
|Nature Reviews Cardiology|2014|134
Inhibition of Aldehyde Dehydrogenase 2 by Oxidative Stress Is Associated with Cardiac Dysfunction in Diabetic Rats
|Molecular Medicine|2010|132
Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice
|Signal Transduction and Targeted Therapy|2022|122